Výsledky vyhledávání - Raymond J. Hohl
- Zobrazuji výsledky 1 - 18 z 18
-
1
-
2
Consequences of Mevalonate Depletion Autor Sarah A. Holstein, Christine Wohlford-Lenane, Raymond J. Hohl
Vydáno 2002Artigo -
3
-
4
The Dopamine D<sub>2</sub> Receptor Contributes to the Spheroid Formation Behavior of U87 Glioblastoma Cells Autor Jillian Weissenrieder, J. Reed, Michelle V. Green, George‐Lucian Moldovan, Emily J. Koubek, Jeffrey D. Neighbors, Raymond J. Hohl
Vydáno 2019Artigo -
5
-
6
VISTA is highly expressed on MDSCs and mediates an inhibition of T cell response in patients with AML Autor Liru Wang, Bei Jia, David F. Claxton, W. Christopher Ehmann, Witold B. Rybka, Shin Mineishi, Seema Naik, Muhammad Rizwan Khawaja, Jeff Sivik, Junyan Han, Raymond J. Hohl, Hong Zheng
Vydáno 2018Artigo -
7
-
8
Bone marrow CD8 T cells express high frequency of PD-1 and exhibit reduced anti-leukemia response in newly diagnosed AML patients Autor Bei Jia, Liru Wang, David F. Claxton, W. Christopher Ehmann, Witold B. Rybka, Shin Mineishi, Syed Rizvi, Hiroko Shike, Michael G. Bayerl, Todd D. Schell, Raymond J. Hohl, Hong Zheng
Vydáno 2018Carta -
9
Blimp-1 impairs T cell function via upregulation of TIGIT and PD-1 in patients with acute myeloid leukemia Autor Liuluan Zhu, Yaxian Kong, Jianhong Zhang, David F. Claxton, W. Christopher Ehmann, Witold B. Rybka, Neil Palmisiano, Ming Wang, Bei Jia, Michael G. Bayerl, Todd D. Schell, Raymond J. Hohl, Hui Zeng, Hong Zheng
Vydáno 2017Artigo -
10
Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma Autor Alessandro Gronchi, B. Bui, Sylvie Bonvalot, S. Pilotti, Stefano Ferrari, Peter Hohenberger, Raymond J. Hohl, George D. Demetri, Axel Le Cesne, Pilar Lardelli, I. Brao Pérez, Antonio Nieto, Juan Carlos Tercero, Vicente Alfaro, Elena Tamborini, Jean‐Yves Blay
Vydáno 2011Artigo -
11
Eomes+T-betlow CD8+ T Cells Are Functionally Impaired and Are Associated with Poor Clinical Outcome in Patients with Acute Myeloid Leukemia Autor Bei Jia, Chenchen Zhao, Kevin Rakszawski, David F. Claxton, W. Christopher Ehmann, Witold B. Rybka, Shin Mineishi, Ming Wang, Hiroko Shike, Michael G. Bayerl, Jeffrey Sivik, Todd D. Schell, Joseph J. Drabick, Raymond J. Hohl, Hong Zheng
Vydáno 2019Artigo -
12
A phase I and pharmacokinetic study of irinotecan in patients with hepatic or renal dysfunction or with prior pelvic radiation: CALGB 9863 Autor Alan P. Venook, Colin Klein, Gini F. Fleming, Donna Hollis, Cynthia G. Leichman, Raymond J. Hohl, John C. Byrd, Daniel R. Budman, Miguel A. Villalona, John L. Marshall, Gary L. Rosner, Jacqueline Ramı́rez, Helen Kastrissios, Mark J. Ratain
Vydáno 2003Artigo -
13
Post-transplant cyclophosphamide alters immune signatures and leads to impaired T cell reconstitution in allogeneic hematopoietic stem cell transplant Autor Chenchen Zhao, Matthew Bartock, Bei Jia, Neal Shah, David F. Claxton, Baldeep Wirk, Kevin Rakszawski, Myles Nickolich, Seema Naik, Witold B. Rybka, W Christopher C. Ehmann, Raymond J. Hohl, Jessica Valentin, Michelle Bernas-Peterson, Emily M. Gerber, Michele Zimmerman, Joseph Mierski, Shin Mineishi, Hong Zheng
Vydáno 2022Carta -
14
Phase I and Pharmacokinetic Study of Sorafenib in Patients With Hepatic or Renal Dysfunction: CALGB 60301 Autor Antonius A. Miller, Daryl J. Murry, Kouros Owzar, Donna Hollis, Erin B. Kennedy, Ghassan K. Abou‐Alfa, Apurva A. Desai, Jimmy J. Hwang, Miguel A. Villalona‐Calero, E. Claire Dees, Lionel D. Lewis, Marwan Fakih, Martin J. Edelman, Fred Millard, Richard C. Frank, Raymond J. Hohl, Mark J. Ratain
Vydáno 2009Artigo -
15
Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial Autor Judith E. Karp, Jeffrey E. Lancet, Scott H. Kaufmann, David W. End, James R. Wright, Kees Bol, Ivan D. Horak, Michael L. Tidwell, Jane L. Liesveld, Timothy Kottke, Dawn Ange, Laxmi Narayana Buddharaju, Ivana Gojo, W. Edward Highsmith, R. T. Belly, Raymond J. Hohl, Mary Ellen Rybak, Alain Thibault, Joseph D. Rosenblatt
Vydáno 2001Artigo -
16
A Phase 2 Cancer Chemoprevention Biomarker Trial of Isoflavone G-2535 (Genistein) in Presurgical Bladder Cancer Patients Autor Edward M. Messing, Jason Gee, Daniel R. Saltzstein, KyungMann Kim, Anthony diSant'Agnese, Jill Kolesar, Linda S. Harris, Adrienne Faerber, Thomas C. Havighurst, Jay M. Young, Mitchell Efros, Robert H. Getzenberg, Marcia A. Wheeler, Joseph A. Tangrea, Howard L. Parnes, Margaret G. House, J. Erik Busby, Raymond J. Hohl, Howard H. Bailey
Vydáno 2012Artigo -
17
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse Autor W.K. Alfred Yung, Robert E. Albright, Jeffrey J. Olson, Ruth K. Fredericks, Karen Fink, Michael D. Prados, M. Brada, A. Spence, Raymond J. Hohl, William Shapiro, Michael Glantz, H. S. Greenberg, Robert G. Selker, Nicholas A. Vick, R. Rampling, Henry S. Friedman, Peter C. Phillips∥, Janet Bruner, N C Yue, David Osoba, Sara Zaknoen, Victor A. Levin
Vydáno 2000Artigo -
18
First-in-Human Phase I Clinical Trial of Pharmacologic Ascorbate Combined with Radiation and Temozolomide for Newly Diagnosed Glioblastoma Autor Bryan G. Allen, Kellie L. Bodeker, Mark C. Smith, Varun Monga, Sonia Sandhu, Raymond J. Hohl, Thomas Carlisle, Heather A. Brown, Nancy Hollenbeck, Sandy Vollstedt, Jeremy D.W. Greenlee, Matthew A. Howard, Kranti A. Mapuskar, Steven N. Seyedin, Joseph M. Caster, Karra A. Jones, Joseph J. Cullen, Daniel Berg, Brett A. Wagner, Garry R. Buettner, M.J. Tennapel, Bruce A. Smith, Douglas R. Spitz, John M. Buatti
Vydáno 2019Artigo
Vyhledávací nástroje:
Související témata
Internal medicine
Medicine
Biology
Cancer
Biochemistry
Cancer research
Oncology
Chemistry
Gastroenterology
Immune system
Immunology
Surgery
CD8
Adverse effect
Chemotherapy
Genetics
Leukemia
Myeloid leukemia
Pharmacology
Phases of clinical research
T cell
Cholesterol
Cohort
Cytotoxic T cell
Dopamine
Enzyme
Gene
Gene knockdown
In vitro
Myeloid